This topic contains a solution. Click here to go to the answer

Author Question: Data that has had the PHI elements removed so that an individual cannot be identified is called: ... (Read 51 times)

pepyto

  • Hero Member
  • *****
  • Posts: 547
Data that has had the PHI elements removed so that an individual cannot be identified is called:
 
  A) valid data.
  B) de-identified data.
  C) aggregate data.
  D) complete data.
  E) reliable data.

Question 2

Where are networked devices most likely to be found in a hospital?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Ksh22

  • Sr. Member
  • ****
  • Posts: 297
Answer to Question 1

B

Answer to Question 2

Networked equipment is most common in emergency rooms, operating rooms, and critical and intensive care units. Because a network makes patient information immediately available anywhere in the hospital and allows a specialist to consult with the emergency room online, it can reduce response time in emergencies.




pepyto

  • Member
  • Posts: 547
Reply 2 on: Jul 12, 2018
:D TYSM


Bigfoot1984

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Only one in 10 cancer deaths is caused by the primary tumor. The vast majority of cancer mortality is caused by cells breaking away from the main tumor and metastasizing to other parts of the body, such as the brain, bones, or liver.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library